German health funds in conflict with Ministry
The tension is increasing between the German health funds and thegovernment over the call for immediate short-term measures to counter the need for increases in patient contributions.
A meeting in Berlin between the heads of the leading funds and Klaus Theo, Secretary of State at the Health Ministry, has ended without result, and talks are to resume at the end of August.
The AOK, Barmer and other major health funds have said that if the government fails to produce reform measures, contributions will have to be increased. The funds are divided among themselves over the measures, with the larger businesses calling for improvements to the planned reform of funding compensation to offset the imbalances between wealthy and poorer health funds.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze